Activities ranging from household tasks to outdoor exercises have shown the potential to help symptoms of depression in patients with rheumatoid arthritis.
In an interview with Christine Moutier, MD, psychiatrist and chief medical officer of the American Foundation for Suicide Prevention, she speaks about how the current COVID-19 pandemic presents opportunities to improve suicide prevention efforts on multiple levels.
Smoking increases the metabolism of clonidine through the CYP1A2, which may require the dose to be doubled to have the same plasma concentration as a non-smoker.
Natalia Skritskaya, PhD, Clinical Psychologist and Research Scientist at the Center for Complicated Grief, Columbia School of Social Work in New York gives her take on the subject of complicated grief.
Adolescents’ psychological challenges are increasingly entangled with their experiences online and virtual interactions with their peers on social media. We look at what this means during the COVID-19 pandemic.
Although the cause of Alzheimer disease is not clear, recent advances in research have furthered the understanding of Alzheimer dementia as a continuum.
An interdisciplinary panel formulated recommendations on opioid tapering strategies in primary care, with particular emphasis placed on addressing biopsychosocial perspectives.
After a decades-long global stop of research on psychedelic drugs, investigation of psychedelics in the context of psychiatric disorders is yielding some positive results.
COVID-19 has caused disruptions all across the world. In this piece, we take a look at what working during the pandemic has been like for psychiatric residents, as well as opportunities that the current situation has offered for learning.
This review examines the nerurobiological mechanisms, risk factors, conceptual models, clinical challenges and management for individuals with antidepressant associated hypomania. Greater clarity is required regarding underlying biological mechanisms and the best treatment approaches to assist with clinical decision-making.
Since publication of the last full practice guideline and guideline watch on schizophrenia, there have been a multitude of studies on new pharmacological and nonpharmacological treatments for schizophrenia.
This systematic review further explores whether alterations of the HPA axis that are commonly found in patients with major depressive disorder are due to early life stress or whether the alterations are caused by the MDD itself.
The dual pandemics of COVID-19 and racism as public health crises have led to an awakening among non-Black Americans as to how rampant racism is in the field of psychiatry and other mental health disciplines.
Although brain stimulation techniques are not considered first-line treatments, these are often used in treatment-resistant depression, with electroconvulsive therapy representing the established best therapeutic option for treatment-resistant depression.
Personalized medicine “promises to move beyond data regarding the average effectiveness of treatments to identify the best treatment for any individual.” However, personalized medicine for depression necessitates “identifying characteristics of individuals that reliably predict differences in benefits and/or adverse effects of alternative depression treatments, including both biological and psychosocial treatments.”
As an increasing number of patients are seeking professional treatment for attachment disorders, clinicians need to stay up to date on the latest developments to mitigate the far-reaching effects of these conditions.
Melatonin and other melatonin receptor agonists have demonstrated efficacy in the treatment of circadian rhythm disorders in both pediatric and adult populations.
Sexual dysfunction has a significant impact on quality of life, personal relationships, self-esteem, and recovery, and it is a common cause for nonadherence or discontinuation of medication.
Precision medicine offers a promising therapeutic strategy for patients with Parkinson disease, allowing for tailored treatments which reflect the unique pathophysiology in each patient.
We recently interviewed Jack Turban, MD, a resident physician in psychiatry at The Massachusetts General Hospital in Boston, where he researches the mental health of transgender youth.
A substantial body of research points to a multifaceted link between depression and cardiovascular disease, with rates of depression being 3 times higher in patients with coronary artery disease compared to the general population
